Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Klaria Pharma Holding AB's Enterprise Value is kr212.83 Mil.
Klaria Pharma Holding AB's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 was kr-35.42 Mil. Therefore, Klaria Pharma Holding AB's EV-to-EBIT ratio for today is -6.01.
*** Please note that the current Enterprise Value is calculated using the current market capitalization and the most recently available financial data. If key financial fields—Long-Term Debt & Capital Lease Obligation and Short-Term Debt & Capital Lease Obligation—are recorded as null in the latest reporting period, our data vendor will default to using data from the prior period with valid entries.
Klaria Pharma Holding AB (OSTO:KLAR) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
Klaria Pharma Holding AB's EV-to-EBIT for today is
Klaria Pharma Holding AB's current Enterprise Value is kr212.83 Mil.
Klaria Pharma Holding AB's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-35.42 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
Klaria Pharma Holding AB's EV-to-EBITDA for today is:
Klaria Pharma Holding AB's current Enterprise Value is kr212.83 Mil.
Klaria Pharma Holding AB's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-23.43 Mil.
Klaria Pharma Holding AB's current Enterprise Value is kr212.83 Mil.
Klaria Pharma Holding AB's Revenue for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was kr0.14 Mil.
Klaria Pharma Holding AB's current Enterprise Value is kr212.83 Mil.
Klaria Pharma Holding AB's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-36.04 Mil.
Klaria Pharma Holding AB's current Enterprise Value is kr212.83 Mil.
Klaria Pharma Holding AB's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-36.04 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Klaria Pharma Holding AB Enterprise Value Related Terms
Klaria Pharma Holding AB Enterprise Value Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
OSTO:KLAR vs ZTS, UTHR: Enterprise Value Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Klaria Pharma Holding AB's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Klaria Pharma Holding AB Enterprise Value vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Klaria Pharma Holding AB's Enterprise Value distribution charts can be found below:
* The bar in red indicates where Klaria Pharma Holding AB's Enterprise Value falls into.
Klaria Pharma Holding AB Enterprise Value Calculation
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
Klaria Pharma Holding AB's Enterprise Value for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Enterprise Value of kr212.83 Mil mean?
Klaria Pharma Holding AB (OSTO:KLAR) has a Enterprise Value of kr212.83 Mil as of Jul. 09, 2026. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Klaria Pharma Holding AB and its competitors.
Is Klaria Pharma Holding AB's Enterprise Value too high?
Klaria Pharma Holding AB's current Enterprise Value is kr212.83 Mil. Overall, Klaria Pharma Holding AB has a GF Score™ of 7/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Klaria Pharma Holding AB's Enterprise Value compare to ZTS and UTHR?
Klaria Pharma Holding AB's Enterprise Value of kr212.83 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Enterprise Value for a Drug Manufacturers company?
A good Enterprise Value depends on the Drug Manufacturers industry context. However, Enterprise Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Enterprise Value mean?
A high Enterprise Value can signal that a stock is expensive relative to its fundamentals. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Klaria Pharma Holding AB and its competitors. Klaria Pharma Holding AB's current Enterprise Value is kr212.83 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Klaria Pharma Holding AB stock overvalued right now?
Based on GuruFocus' analysis, Klaria Pharma Holding AB (OSTO:KLAR) is currently considered Significantly Overvalued. The stock's GF Value™ is kr0.32, compared to a current price of kr0.77 — trading 139.1% above its estimated fair value. The current Enterprise Value is kr212.83 Mil. Klaria Pharma Holding AB's overall GF Score™ is 7/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Enterprise Value calculated?
Enterprise Value is calculated from a company's financial statements. For Klaria Pharma Holding AB (OSTO:KLAR), the current Enterprise Value is kr212.83 Mil as of Jul. 09, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Klaria Pharma Holding AB (OSTO:KLAR) Overvalued in 2026?
Based on GuruFocus' analysis, Klaria Pharma Holding AB stock appears to be overvalued.
The current stock price of kr0.77 is trading 139.1% above its estimated GF Value™ of kr0.32.
GuruFocus considers Klaria Pharma Holding AB to be Significantly Overvalued.
Key valuation signals for OSTO:KLAR:
Enterprise Value: kr212.83 Mil
GF Value™: kr0.32 vs. price of kr0.77 (139.1% above fair value)
No single metric tells the full story. See the OSTO:KLAR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Klaria Pharma Holding AB is a Swedish pharmaceutical company that develops rapid-acting products. By combining patented technology of a film that attaches to the oral mucosa and pharmaceuticals, the company has developed a drug distribution concept with many benefits and potential uses. Its patented drug delivery platform consists of an alginate-based polymer film that enables the absorption of a product's active substance through the oral mucosa.
7GF Score
Get the complete analysis for OSTO:KLAR
Enterprise Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OSTO:KLAR has been successfully added to your 
